Diabetes Therapy 14(4):723736 Do D, Lee T, Peasah SK, Good CB, Inneh A, Patel U (2024) PMPH GLP-1 receptor agonist discontinuation among patients with obesity and/or type 2 diabetes
We understand that every persons weight loss and health journey is unique
This work was supported by the Funds of National Natural Science Foundation of China (82060728), Guizhou Provincial Science and Technology Department (MS [2025-380], Thousand Talents Program), Talents of Guizhou Science and Technology Platform [2021]1350-009, Zunyi Science and Technology Bureau (HZ-2023-173, HZ-2023-09, [2024] No
Slowing Gastric Emptying: GLP drugs slow down the rate at which food leaves the stomach, helping people feel full longer after meals, further reducing hunger and calorie consumption
L-Carnitine offers an alternative for patients focused specifically on fat oxidation